Evidence map›Paper›PMID 34172086›Full record

ArticleAlzheimer's research & therapy2021

Pathological correlates of impaired self-awareness of memory function in Alzheimer's disease.

Geoffroy Gagliardi, Madeline Kuppe, Cristina Lois, Bernard Hanseeuw, Patrizia Vannini, Alzheimer’s Disease Neuroimaging Initiative

Abstract read
In one paragraph

Article in Alzheimer's research & therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Geoffroy GagliardiBrigham and Women's Hospital, Boston, MA, USA. ggagliardi@bwh.harvard.edu.ORCID 0000-0002-2608-8456
Madeline KuppeMassachusetts General Hospital, Boston, MA, USA.
Cristina LoisMassachusetts General Hospital, Boston, MA, USA.
Bernard HanseeuwMassachusetts General Hospital, Boston, MA, USA.
Patrizia VanniniBrigham and Women's Hospital, Boston, MA, USA.
Alzheimer’s Disease Neuroimaging Initiative

Funding

Decoding neural systems underlying anosognosia for memory loss in aging and Alzheimer's diseaseR01AG061083 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI VANNINI, PATRIZIA · 2019 to 2023
$4.3M
Novel diffusion-weighted MRI assessment of cortical microstructural changes and their relationship to amyloid, tau and cognition in aging and Alzheimer's disease.R21AG064348 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI VANNINI, PATRIZIA · 2019 to 2020
$492k
NIA NIH HHS R01 AG061083
6 · The paper itself

Abstract

introductionImpaired self-awareness of memory function, a.k.a. anosognosia, is a common symptom in Alzheimer's disease (AD); however, its pathological correlates remain unclear. Here, we investigated the impact of amyloid and tau on memory self-awareness.

methodsTwo hundred thirty-six clinically normal (N) and 102 impaired (I) participants from the ADNI cohort were included. Amyloid (global) and tau burden (in entorhinal and inferior temporal cortices) were assessed using positron emission tomography (PET). Self-awareness of memory was assessed using discrepancy indexes of subjective participant-informant ratings, as well as participant-objective scores of memory performance. Subjective and objective values were derived from the Everyday Cognition memory questionnaire and Logical Memory (delayed recall).

resultsLower awareness (both methods) of memory function was associated with higher levels of pathology in the I group as compared to N. There was a significant effect of tauopathy, but not amyloidosis, on individual complaint, such that higher levels of tau associated with lower awareness. DISCUSSION: Impaired self-awareness appears progressively in the evolution of the disease related to AD biomarkers. Discordant subjective and objective measures may be important for clinical consideration.

Indexed as

Alzheimer DiseaseCognitive DysfunctionTauopathiesAmyloid beta-PeptidesHumansPositron-Emission Tomographytau ProteinsTemporal LobeAmyloid beta-Peptidestau ProteinsAlzheimer’s diseaseAmyloidAwarenessCognitionTau

Identifiers

PMID34172086
PMCPMC8234669

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.